CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ChangChun High New Technology Industries Company Snapshot
ChangChun High New Technology Industries operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares ChangChun High New Technology Industries with three other companies in this sector in CHINA : Apeloa Pharmaceutical Co Ltd (2019 sales of 7.21 billion Chinese Renmimbi [US$1.01 billion] of which 100% was Health Care & Pharmaceutical), Zhejiang Nhu Co Ltd (7.62 billion Chinese Renmimbi [US$1.07 billion] of which 94% was Pharmaceutical Chemicals), and Shandong Xinhua Pharmaceutical Company Limited (5.61 billion Chinese Renmimbi [US$785.46 million] of which 57% was Preparations).

Sales Analysis. During the year ended December of 2019, sales at ChangChun High New Technology Industries were 7.27 billion Chinese Renmimbi (US$1.02 billion). This is an increase of 36.7% versus 2018, when the company's sales were 5.32 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at ChangChun High New Technology Industries (and since 2014, sales have increased a total of 226%). Sales of Real Estates saw an increase of 57.7% in 2019, from 606.83 million Chinese Renmimbi to 956.78 million Chinese Renmimbi. Not all segments of ChangChun High New Technology Industries experienced an increase in sales in 2019: sales of Service Industry fell 43.8% to 14.29 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ChangChun High New Technology Industries
  Stock Performance Chart for ChangChun High New Technology Industries
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 650.30
(Figures in Chinese Renmimbi)
1 Week 1.4%   13 Weeks 13.1%  
4 Weeks 33.0%   52 Weeks 119.0%  
 
ChangChun High New Technology Industries Key Data:
  Ticker: 000661 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 7,274,494,913
(Year Ending Jan 2020).
Employees: 5,535
  Currency: Chinese Renmimbi Market Cap: 131,594,802,294
  Fiscal Yr Ends: December Shares Outstanding: 202,360,145
  Share Type: A Gu Closely Held Shares: 43,941,302
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.